Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

医学 部分流量储备 经皮冠状动脉介入治疗 生活质量(医疗保健) 置信区间 冠状动脉疾病 质量调整寿命年 成本效益 经皮 心脏病学 内科学 急诊医学 冠状动脉造影 心肌梗塞 风险分析(工程) 护理部
作者
William F. Fearon,Bernhard Bornschein,Pim A.L. Tonino,Raffaella Matteucci Gothe,Bernard De Bruyne,Nico H.J. Pijls,Uwe Siebert
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:122 (24): 2545-2550 被引量:358
标识
DOI:10.1161/circulationaha.109.925396
摘要

The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) study demonstrated significantly improved health outcomes at 1 year in patients randomized to multivessel percutaneous coronary intervention guided by fractional flow reserve (FFR) compared with percutaneous coronary intervention guided by angiography alone. The economic impact of routine measurement of FFR in this setting is not known.In this study, 1005 patients were randomly assigned to FFR-guided or angiography-guided percutaneous coronary intervention and followed up for 1 year. A prospective cost-utility analysis comparing costs and quality-adjusted life-years was performed with a time horizon of 1 year. Quality-adjusted life-years were calculated with the use of utilities determined by the EuroQuol 5 dimension health survey with US weights. Direct medical costs included those of the index procedure and hospitalization and costs for major adverse cardiac events during follow-up. Confidence intervals for both quality-adjusted life-years and costs were estimated by the bootstrap percentile method. Major adverse cardiac events at 1 year occurred in 13.2% of those in the FFR-guided arm and 18.3% of those in the angiography-guided arm (P=0.02). Quality-adjusted life-years were slightly greater in the FFR-guided arm (0.853 versus 0.838; P=0.2). Mean overall costs at 1 year were significantly less in the FFR-guided arm ($14 315 versus $16 700; P<0.001). Bootstrap simulation indicated that the FFR-guided strategy was cost-saving in 90.74% and cost-effective at a threshold of US $50 000 per quality-adjusted life-years in 99.96%. Sensitivity analyses demonstrated robust results.Economic evaluation of the FAME study reveals that FFR-guided percutaneous coronary intervention in patients with multivessel coronary disease is one of those rare situations in which a new technology not only improves outcomes but also saves resources. Clinical Trial Registration- URL: http://ClinicalTrials.gov. Unique identifier: NCT00267774.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wencher完成签到,获得积分10
刚刚
1秒前
1秒前
LV发布了新的文献求助10
1秒前
2秒前
神勇从波发布了新的文献求助10
2秒前
哎呀完成签到,获得积分10
2秒前
昊康好完成签到,获得积分10
2秒前
在下想完成签到 ,获得积分10
2秒前
颖子发布了新的文献求助10
3秒前
bdsb完成签到,获得积分10
4秒前
程程完成签到,获得积分10
4秒前
Mcarry完成签到,获得积分10
4秒前
楠珊完成签到,获得积分10
5秒前
re发布了新的文献求助10
5秒前
5秒前
机灵石头完成签到,获得积分10
5秒前
JFP完成签到,获得积分10
6秒前
傻瓜完成签到 ,获得积分10
7秒前
吨吨吨发布了新的文献求助10
7秒前
ajiwjn完成签到,获得积分10
7秒前
Jiao H.P完成签到,获得积分10
8秒前
琉璃岁月完成签到,获得积分10
8秒前
宁语完成签到,获得积分10
8秒前
dlut0407完成签到,获得积分10
8秒前
马上动起来完成签到,获得积分10
8秒前
胡图图完成签到,获得积分10
9秒前
合适忆南完成签到,获得积分10
9秒前
努力退休小博士完成签到 ,获得积分10
10秒前
傅英俊完成签到,获得积分10
10秒前
冷傲的迎南完成签到 ,获得积分10
10秒前
55完成签到,获得积分10
11秒前
易槐完成签到,获得积分10
11秒前
zhao完成签到 ,获得积分10
11秒前
cyw完成签到,获得积分10
11秒前
xiaoxu完成签到,获得积分10
12秒前
12秒前
情怀应助西子阳采纳,获得10
12秒前
研途者完成签到,获得积分10
13秒前
阳光晟睿完成签到,获得积分20
13秒前
高分求助中
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Animal Physiology 2000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
CENTRAL BOOKS: A BRIEF HISTORY 1939 TO 1999 by Dave Cope 1000
Resilience of a Nation: A History of the Military in Rwanda 888
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3742459
求助须知:如何正确求助?哪些是违规求助? 3285014
关于积分的说明 10042803
捐赠科研通 3001641
什么是DOI,文献DOI怎么找? 1647494
邀请新用户注册赠送积分活动 784239
科研通“疑难数据库(出版商)”最低求助积分说明 750676